COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 2353: Articles 23521-23530  | Next

Bioinformatic Analysis Reveals That Some Mutations May Affect On Both Spike Structure Damage and Ligand Binding Site
Aktas, E.
10.1101/2020.08.10.244632 — Posted: 2020-08-10
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France
Queromes, G., Destras, G., Bal, A., Regue, H., Burfin, G., Brun, S., Fanget, R., Morfin, F., Valette, M., Lina, B., Frobert, E., Josset, L.
10.1101/2020.08.07.241653 — Posted: 2020-08-10
K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia
Perlman, S., Zheng, J., WONG, L. Y. R., Li, K., Verma, A. K., Ortiz Bezara, M. E., Wohlford-Lenane, C., Leidinger, M. R., Kundson, M. C., Meyerholz, D. K., McCray, P. B.
10.1101/2020.08.07.242073 — Posted: 2020-08-10
SARS-CoV-2 Quasispecies Mediate Rapid Virus Evolution and Adaptation
Chaudhry, M. Z., Eschke, K., Grashoff, M., Abassi, L., Kim, Y., Brunotte, L., Ludwig, S., Safranko, Z. M., Kurolt, I.-C., Markotic, A., Kroeger, A., Klawonn, F., Cicin-Sain, L.
10.1101/2020.08.10.241414 — Posted: 2020-08-10
SARS-CoV-2 and the Role of Orofecal Transmission: Systematic Review
Heneghan, C., Spencer, E., Brassey, J., Jefferson, T.
10.1101/2020.08.04.20168054 — Posted: 2020-08-10
A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential
Gai, J., Ma, L., Li, G., Zhu, M., Qiao, P., Li, X., Zhang, H., Zhang, Y., Chen, Y., Gong, R., Wan, Y.
10.1101/2020.08.09.242867 — Posted: 2020-08-10
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial
Zhang, Y.-J., Zeng, G., Pan, H.-X., Li, C.-G., Kan, B., Hu, Y.-L., Mao, H.-Y., Xin, Q.-Q., Chu, K., Han, W.-X., Chen, Z., Tang, R., Yin, W.-D., Chen, X., Gong, X.-J., Qin, C., Hu, Y.-S., Liu, X.-Y., Cui, G.-L., Jiang, C.-B., Zhang, H.-M., Li, J.-X., Yang, M.-N., Lian, X.-J., Song, Y., Lu, J.-X., Wang, X.-X., Xu, M., Gao, Q., Zhu, F.-C.
10.1101/2020.07.31.20161216 — Posted: 2020-08-10 Discussion: Offsite
SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for reverse zoonosis to New World rodents
Fagre, A., Lewis, J., Eckley, M., Zhan, S., Rocha, S. M., Sexton, N. R., Burke, B., Geiss, B. J., Peersen, O., Kading, R., Rovnak, J., Ebel, G. D., Tjalkens, R. B., Aboellail, T., Schountz, T.
10.1101/2020.08.07.241810 — Posted: 2020-08-07
mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
Hassert, M., Geerling, E., Stone, E. T., Steffen, T. L., Dickson, A., Feldman, M. S., Class, J., Richner, J. M., Brien, J. D., Pinto, A. K.
10.1101/2020.08.07.241877 — Posted: 2020-08-07
Expression of ACE2, TMPRSS2, and CTSL in human airway epithelial cells under physiological and pathological conditions: Implications for SARS-CoV2 infection
Yin, J., Kasper, B., Petersen, F., Yu, X.
10.1101/2020.08.06.240796 — Posted: 2020-08-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).